Modulation of the p27kip1 Cyclin-Dependent Kinase Inhibitor Expression during IL-4-Mediated Human B Cell Activation 1

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3054-3061

  Blanchard, Dominique Alain ^a   Affredou, Marie Thérèse ^a   Vazquez, Aime ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; CD40 ANTIGEN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; MICROTUBULE ASSOCIATED PROTEIN; MONOCLONAL ANTIBODY; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; TONSIL; UPREGULATION;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; B-LYMPHOCYTES; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-13; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTE ACTIVATION; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TONSIL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0031111909     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Noelle, R., P. H. Klammer, J. Ohara, J. W. Uhr, and E. S. Vitetta. 1984. Increased expression of Ia antigens in resting B cells: an additional role for B cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149.
2. Defrance, T., J. P. Aubry, F. Rousset, B. Vanbervliet, J. Y. Bonnefoy, N. Arai, T. Takabe, Y. Yokota, F. Lee, K. Arai, J. E. deVries, and J. Banchereau. 1987. Human recombinant interleukin 4 induced Fc∈ receptors (CD23) on normal B lymphocytes. J. Exp. Med. 165:1459.
3. Rousset, F., R. de Waal Malefijt, B. Slierenregt, J. P. Aubry, J. Y. Bonnefoy, T. Defrance, J. Banchereau, and J. E. de Vries. 1988. Modulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-γ. J. Immunol. 140:2625.
4. Shields, J. G., R. J. Armitage, B. N. Jamieson, P. C. Beverley, and R. E. Callard. 1989. Increased expression of surface IgM but not IgD or IgG on human B-cells in response to IL-4. Immunology 66:224.
5. Howard, M., J. Farrar, M. Hilkifer, B. Johnson, K. Takatsu, T. Hamaoka, and W. E. Paul. 1982. Identification of a T cell derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914.
6. Defrance, T., B. Vanbervliet, J. P. Aubry, T. Takabe, N. Arai, A. Miyajima, Y. Yokota, F. Lee, K. Arai, J. E. deVries, and J. Banchereau. 1987. B cell growth-promoting activity of recombinant human interleukin 4. J. Immunol. 139:1135.
7. Clark, E. A., G. L. Shu, B. Luscher, K. E. Draves, J. Banchereau, J. A. Ledbetter, and M. A. Valentine. 1989. Activation of human B cells: comparison of the signal transduced by IL-4 to four different competence signals. J. Immunol. 142:3873.
8. Banchereau, J., P. Paoli, A. Vallé, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
9. Seyschab, H., H. Hoehn, P. Rabinovitch, and U. Chen. 1991. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2′-deoxyuridine/Hoechst 33258 dye flow cytometry. Eur. J. Immunol. 21:2153.
10. Hodgkins, P. D., N. F. Go, J. E. Cupp, and M. Howard. 1991. Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal. Cell. Immunol. 134:14.
11. Karray, S., T. Defrance, H. Merle-Beral, J. Banchereau, P. Debre, and P. Galanaud. 1988. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. J. Exp. Med. 168:85.
12. Jelinek, D. F., and P. E. Lipsky. 1988. Inhibitory influence of IL-4 on human B cell responsiveness. J. Immunol. 141:164.
13. Vazquez, A., S. Mills, and A. Maizel. 1989. Modulation of IL.2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4. J. Immunol. 142:94.
14. Taieb, J., G. Leca, M. T. Auffredou, P. Galanaud, and A. Vazquez. 1991. IL.4 counteracts anti-μ-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway. Eur. Cytokine Netw. 2:265.
15. Taieb, J., M. T. Auffredou, and A. Vazquez. 1994. B-T cell interactions modulate inhibitory effects of/L-4 on human B cell proliferation. Eur. J. Immunol. 24:480.
16. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059.
17. Hunter, T., and J. Pines. 1994. Cyclins and cancer. H. Cyclin D and CDK inhibitors come of age. Cell 79:573.
18. Doree, M., and S. Galas. 1994. The cyclin-dependent protein kinases and the control of cell division. FASEB J. 8:1114.
19. Matsushime, H., M. E. Ewen, D. K. Strom, J. Y. Kato, S. K. Hanks, M. F. Roussel, and C. J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323.
20. Bates, S., L. Bonetta, D. MacAllan, D. Parry, A. Holder, C. Dickson, and G. Peters. 1994. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9:71.
21. Meyerson, M., and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077.
22. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424.
23. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499.
24. Ewen, M. E., H. K. Stass, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487.
25. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331.
26. LaThangue, N. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108.
27. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79:547.
28. Hirama, T., and H. P. Koeffler. 1995. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841.
29. Peter, M., A. Gartner, J. Horecka, G. Ammerer, and I. Herskowitz. 1993. FAR1 links the signal rransduction pathway to the cell cycle machinery in yeast. Cell 73:747.
30. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066.
31. Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:1713.
32. Matsuoka, M., J. Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265.
33. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149.
34. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704.
35. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572.
36. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257.
37. Hebert, J., J. M. Cayuela, J. Berkeley, and F. Sigaux. 1994. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 84:4038.
38. Parry, D., S. Bates, D. J. Mann, and G. Peters. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14:503.
39. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases Nature 366:701.
40. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805.
41. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707.
42. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750.
43. Polyak, K., M. H. Lee, B. H. Erdjument, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
44. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67.
45. Slingerland, J. M., L. Hengst, C. H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14:3683.
46. Parker, L. L., and W. H. Piwnica. 1992. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257:1955.
47. Jiang, H., J. Lin, Z. Z. Su, F. R. Collait, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397.
48. Noda, A., Y. Ning, S. F. Venable, S. O. Pereira, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211:90.
49. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. El Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389.
50. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013.
51. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018.
52. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889.
53. Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291.
54. Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
55. Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487.
56. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570,
57. Rolling, C., D. Treton, P. Beckmann, P. Galanaud, and Y. Richard. 1995. JAK3 associates with the human Interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering. Oncogene 10:1757.
58. Welham, M. J., L. Learmonth, H. Bone, and J. W. Schrader. 1995. Interleukin-13 signal transduction in lymphohemopoietic cells. J. Biol. Chem. 270:12286.
59. Ryan, J. J., J. L. McReynolds, A. Keegan, H. L. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123.
60. Chaouchi, N., C. Wallon, C. Goujard, G. Tertian, A. Rudent, D. Caput, P. Ferrera, A. Minty, A. Vazquez, and J. F. Delfraissy. 1996. Interleukin-13 inhibits interleukin-2 induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022.
61. Ajchenbaum, F., K. Ando, J. A. DeCaprio, and J. D. Griffin. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
62. Solvason, N., W. W. Wu, N. Kabra, X. Wu, E. Lees, and M. Howard. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulins-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
63. Punnonen, J., G. Aversa, B. G. Cocks, A. N. J. McKenzie, S. Menson, G. Zurawski, R. Waal Malefytt, and J. E. de Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730.
64. Defrance, T., P. Carayon, G. Billian, J. C. Guillemot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179: 135.
65. Furukawa, Y., W. H. Piwnica, T. J. Ernst, Y. Kanakura, and J. D. Griffin. 1990. cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science 250:805.
66. Palmero, I., A. Holder, A. J. Sinclair, C. Dickson, and G. Peters. 1993. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8: 1049.
67. Modiano, J. F., J. Domenico, A. Szepesi, J. J. Lucas, and E. W. Gelfand. 1994. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269:32972.
68. Lucas, J. J., A. Szepesi, J. F. Modiano, J. Domenico, and E. W. Gelfand. 1995. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. J. Immunol. 154:6275.
69. Takase, K., N. Terada, J. J. Lucas, and E. W. Gelfand. 1995. Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes. J. Cell Physiol. 162:246.
70. Tanguay, D. A., and T. C. Chiles. 1996. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539.
71. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154:4341.
72. Sinclair, A. J., I. Palmero, G. Peters, and P. J. Farrell. 1994. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321.
73. Arvanitakis, L., N. Yaseen, and S. Sharma. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J . Immunol. 155:1047.
74. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701.
75. Mongini, P. K. A., P. F. Highet, and J. K. Inman. 1995. Effect of T cell cytokines on the physiochemical binding requirement for achieving cell cycle progression via the membrane IgM signaling pathway. J. Immunol. 155:3385.
76. Finney, M., G. R. Guy, R. H. Michell, J. Gordon, B. Dugas, K. P. Rigley, and R. E. Callard. 1990. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 20:151.
77. Vazquez, A., M. T. Auffredou, P. Galanaud, and G. Leca. 1991. Modulation of IL-2 and IL-4-dependent human B cell proliferation by cyclic AMP. J. Immunol. 146:4222.
78. Karray, S., A. Dautry-Varsat, M. Tsudo, H. Merle-Beral, P. Debre, and P. Galanaud. 1990. IL-4 inhibits the expression of high-affinity IL-2 receptors on monoclonal human B cells. J. Immunol. 145:1152.
79. Moreau, J. L., P. Chastagner, T. Tanaka, M. Miyasaka, M. Kondo, K. Sugamura, and J. Theze. 1995. Control of the IL-2 responsiveness of B lymphocytes by IL-2 and IL-4. J. Immunol. 155:3401.